Ventricular arrhythmia in chronic kidney disease patients

Area of Science:

• Nephrology
• Cardiology
• Clinical Medicine

Background:

• Patients with chronic kidney disease (CKD) have a high susceptibility to ventricular arrhythmias.
• Cardiac arrhythmias are the primary cause of mortality in patients undergoing dialysis.
• The complex pathophysiology involves CKD-related cardiac abnormalities and various triggers like electrolyte imbalances and dialysis procedures.

Purpose of the Study:

• To review the clinical outcomes of asymptomatic ventricular arrhythmias in CKD patients.
• To discuss the often-neglected clinical aspects of arrhythmias in the CKD population.
• To explore the controversial treatment outcomes for anti-arrhythmic drugs and invasive devices in this patient group.

Main Methods:

• Literature review of clinical outcomes and treatment strategies for ventricular arrhythmias in CKD patients.
• Analysis of studies focusing on asymptomatic ventricular arrhythmias in the context of chronic kidney disease.
• Synthesis of available data on the efficacy and controversy surrounding anti-arrhythmic drugs and invasive devices.

Main Results:

• Clinical outcomes for CKD patients with asymptomatic ventricular arrhythmias are not well-established.
• Treatment strategies, including anti-arrhythmic drugs and invasive devices, show controversial results in the CKD population.
• The complex interplay of CKD, cardiac structure, and various triggers contributes to arrhythmia development.

Conclusions:

• Further research is needed to clarify the clinical outcomes and optimal management of ventricular arrhythmias in CKD patients.
• The current literature provides controversial evidence regarding the effectiveness of anti-arrhythmic drugs and invasive devices.
• Addressing this neglected topic is crucial for improving the survival and quality of life in the CKD population.